ALDH1A3 and type 2 diabetes mellitus: In type 2 diabetes and vascular proliferation diseases, ALDH1a3 has become a standard marker of cellular dedifferentiation (Fig. 3), particularly in failing pancreatic β cells of both patients and mouse models (Davey et al., 2020; Kim-Muller et al., 2016; Wang et al., 2020).